Zimmermann, Karin
,
Cignacco, Eva
Engberg, Sandra
Ramelet, Anne-Sylvie
von der Weid, Nicolas
Eskola, Katri
Bergstraesser, Eva
Ansari, Marc
Aebi, Christoph
Baer, Reta
Popovic, Maja Beck
Bernet, Vera
Brazzola, Pierluigi
Bucher, Hans Ulrich
Buder, Regula
Cagnazzo, Sandra
Dinten, Barbara
Dorsaz, Anouk
Elmer, Franz
Enriquez, Raquel
Fahrni-Nater, Patricia
Finkbeiner, Gabi
Frey, Bernhard
Frey, Urs
Greiner, Jeannette
Hassink, Ralph-Ingo
Keller, Simone
Kretschmar, Oliver
Kroell, Judith
Laubscher, Bernard
Leibundgut, Kurt
Malaer, Reta
Meyer, Andreas
Stuessi, Christoph
Nelle, Mathias
Neuhaus, Thomas
Niggli, Felix
Perrenoud, Geneviève
Pfammatter, Jean-Pierre
Plecko, Barbara
Rupf, Debora
Sennhauser, Felix
Stade, Caroline
Steinlin, Maja
Stoffel, Lilian
Thomas, Karin
Vonarburg, Christian
von Vigier, Rodo
Wagner, Bendicht
Wieland, Judith
Wernz, Birgit
Funding for this research was provided by:
Swiss Cancer League/Swiss Cancer Research (KFS-3008-08-2012)
Nursing Science Foundation, Switzerland
Federal Office of Public Health, Switzerland
Start Stipend Award, PhD Program in Health Sciences, University of Basel
Article History
Received: 19 October 2016
Accepted: 29 January 2018
First Online: 16 February 2018
Ethics approval and consent to participate
: Human Research Ethics Committees from the 11 Swiss cantons in which the study took place approved the PELICAN study (leading committee: Kantonale Ethikkommission Zürich, KEK ZH Nr. 2012-0537). Parents of eligible deceased children were informed and invited to participate in the study by the former treating team, who also acted as gatekeeper as needed. Participation was entirely voluntary and written informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.